Clinical trial for Tobacco Use
Official title Overcoming Nicotine Dependence to Enable Quitting
ClinicalTrials.gov ID: NCT05513872
What this study is testing
What is Nicotine Replacement Therapy (NRT) Sampling?
An investigational 4‑week starter kit of nicotine lozenges and patches being studied as a potential treatment for tobacco use disorder. It is designed to deliver low levels of nicotine to the body to reduce cravings and withdrawal symptoms associated with quitting smoking.
Also referred to as NRT.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to learn which type of counseling and whether giving a short supply of nicotine lozenges and patches best encourages smokers to practice quitting for a few hours or days.
- Who it's for
- Adults who currently smoke cigarettes and are willing to try short‑term quitting, even if they are not ready to set a quit date.
- What's involved
- Participants will receive either practice‑quitting counseling or motivational‑interviewing counseling, and some will be given a four‑week supply of nicotine lozenges and patches. They will attend study visits and complete questionnaires about their smoking.
- Time commitment
- The study lasts about four weeks of treatment with several clinic visits during that time.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligible participants will be males and females who:
- are 18 years or older
- report current daily cigarette smoking (≥ 5 cigarettes per day)
- are not planning to quit in the next 30 days
- are not currently engaged in smoking cessation treatment
You likely can't join if
- Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications...
- are pregnant/breastfeeding
- had recent cardiovascular trauma such as myocardial infarction
- had a stroke within the past 3 months
See the full eligibility criteria
- Eligible participants will be males and females who:
- are 18 years or older
- report current daily cigarette smoking (≥ 5 cigarettes per day)
- are not planning to quit in the next 30 days
- are not currently engaged in smoking cessation treatment
- are motivated to quit or engage in a non-cessation goal (i.e., reduce smoking, learn more about treatment options, and/ or try out skills to change smoking) in the next 6 months
- are English speaking
- reside in the continental United States
- have access to a smartphone that can be used to complete study procedures
- Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications for NRT use if they:
- are pregnant/breastfeeding
- had recent cardiovascular trauma such as myocardial infarction
- had a stroke within the past 3 months
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.